<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Publications</title>
  <link rel="stylesheet" href="css/style.css">
</head>

<body>

<nav>
  <div class="nav-container">
    <span class="logo">Marta Cipriani</span>
    <ul>
      <li><a href="index.html">About</a></li>
      <li><a href="publications.html">Publications</a></li>
      <li><a href="contact.html">Contact</a></li>
    </ul>
  </div>
</nav>

<h1 class="section-title">Publications</h1>
  
<!-- ================= FLEX CONTAINER ================= -->
<div class="pub-container">

  <!-- ===== COLONNA SINISTRA ===== -->
  <div class="pub-column left">

    <!-- ===== SCIENTIFIC PAPERS ===== -->
    <section>
      <h2>Scientific papers</h2>
      <ul class="pub-list">

        <li><strong>A flexible parametric approach to synthetic patients generation using health data</strong><br>
            M. Cipriani, L. Di Rocco, M. Puopolo, M. Alfò<br>
            <em>Statistical Methods and Applications</em>, 34, 639–662, 2025.
            <a href="https://doi.org/10.1007/s10260-025-00800-5" target="_blank">DOI</a>
        </li>

        <li><strong>Health-Related Quality of Life and Financial Burden in Ethiopian Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Study</strong><br>
            F. Tadesse, F. Sparano, A. Gebremedhin, A. Abubeker, A. Piciocchi, M. Cipriani <em>et al.</em><br>
            <em>JCO Global Oncology</em>, 10:e2400281, 2024.
            <a href="https://doi.org/10.1200/GO-24-00281" target="_blank">DOI</a>
        </li>

        <li><strong>Current Knowledge on Breast Implant‑Associated Anaplastic Large Cell Lymphoma: Evidence from Italian Ministry of Health Registry Data</strong><br>
            A. Campanale, M. Ventimiglia, M. Alfò, M. Cipriani, D. Minella, L. Lispi, A. Iachino<br>
            <em>Aesthetic Plastic Surgery</em>, 49(5), 1304–1313, 2024.
            <a href="https://doi.org/10.1007/s00266-024-04426-y" target="_blank">DOI</a>
        </li>

        <li><strong>Health‑related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO‑SKKI Trial</strong><br>
            F. Efficace, F.‑X. Mahon, J. Richter, A. Piciocchi, M. Cipriani <em>et al.</em><br>
            <em>Leukemia</em>, 38(8), 1722–1730, 2024.
            <a href="https://doi.org/10.1038/s41375-024-02341-4" target="_blank">DOI</a>
        </li>

        <li><strong>Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients</strong><br>
            A. Piciocchi, M. Cipriani, M. Messina, G. Marconi, V. Arena <em>et al.</em><br>
            <em>eJHaem</em>, 5(2), 353–359, 2023.
            <a href="https://doi.org/10.1002/jha2.873" target="_blank">DOI</a>
        </li>

        <li><strong>A randomized double-blind clinical trial on safety and efficacy of TUDCA as add-on treatment in ALS: the statistical analysis plan of TUDCA-ALS trial</strong><br>
            F. L. Lombardo, S. Spila Alegiani, F. Mayer, M. Cipriani <em>et al.</em><br>
            <em>Trials</em>, 24, 792, 2023.
            <a href="https://doi.org/10.1186/s13063-023-07638-w" target="_blank">DOI</a>
        </li>

        <li><strong>The Promotoer, a brain-computer interface-assisted intervention to promote upper limb functional motor recovery after stroke: a statistical analysis plan</strong><br>
            M. Cipriani, F. Pichiorri, E. Colamarino, J. Toppi, F. Tamburella, M. Lorusso <em>et al.</em><br>
            <em>Trials</em>, 24, 736, 2023.
            <a href="https://doi.org/10.1186/s13063-023-07773-4" target="_blank">DOI</a>
        </li>

        <li><strong>Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting</strong><br>
            E. Attardi, A. Savi, B. Borsellino, A. Piciocchi, M. Cipriani <em>et al.</em><br>
            <em>Blood Adv</em>, 7(17), 5122–5131, 2023.
            <a href="https://doi.org/10.1182/bloodadvances.2023010173" target="_blank">DOI</a>
        </li>

        <!-- aggiungi qui tutte le altre scientific papers come sopra -->

      </ul>
    </section>

    <!-- ===== PROCEEDINGS ===== -->
    <section>
      <h2>Proceedings</h2>
      <ul class="pub-list">

        <li><strong>Missing Covariates in Mixture Cure Models: A Multiple Imputation Approach</strong><br>
            M. Cipriani, M. Fiocco, M. Alfò, E. Musta<br>
            <em>Statistics for Innovation II</em>, Springer, 2025.
            <a href="https://doi.org/10.1007/978-3-031-96303-2_75" target="_blank">DOI</a>
        </li>

        <li><strong>A Flexible Parametric Approach to Synthetic Patients Generation in Clinical Trials</strong><br>
            M. Cipriani, L. Di Rocco, M. Alfò<br>
            <em>Methodological and Applied Statistics and Demography III</em>, Springer, 2025.
            <a href="https://doi.org/10.1007/978-3-031-64431-3_69" target="_blank">DOI</a>
        </li>

        <li><strong>Digital Twins As Control Groups to Accelerate Assessment of Safety and Efficacy of Novel Treatment Strategies in Ph‑Negative ALL</strong><br>
            A. Piciocchi, M. Messina, G. Marsili, M. Cipriani <em>et al.</em><br>
            <em>Blood</em>, 144 Suppl.1, 274–275, 2024.
            <a href="https://doi.org/10.1182/blood-2024-200643" target="_blank">DOI</a>
        </li>

        <li><strong>A Propensity Score Weighting Analysis Emphasizes the Progress of the Gimema Approach in Adult Ph-Positive Acute Lymphoblastic Leukemia in the TKI Era</strong><br>
        A. Piciocchi, S. Chiaretti, M. Cipriani, M. Messina <em>et al.</em><br>
        <em>Blood</em>, 142 Suppl.1, p. 4200, 2023.
        <a href="https://doi.org/10.1182/blood-2023-179102" target="_blank">DOI</a>
    </li>

    <li><strong>Unraveling the Impact of 2022 Classifications on Secondary Acute Myeloid Leukemia: Assessing the True Qualification Power of Diagnostic Qualifiers</strong><br>
        E. Attardi, A. Savi, B. Borsellino, M. Cipriani, A. Piciocchi <em>et al.</em><br>
        <em>Blood</em>, 142 Suppl.1, p. 819, 2023.
        <a href="https://doi.org/10.1182/blood-2023-185709" target="_blank">DOI</a>
    </li>

    <li><strong>P499: Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting</strong><br>
        E. Attardi, A. Savi, B. Borsellino, A. Piciocchi, M. Cipriani <em>et al.</em><br>
        <em>HemaSphere</em>, 7 (Suppl), e5402602, 2023.
        <a href="https://doi.org/10.1097/01.HS9.0000968904.54026.02" target="_blank">DOI</a>
    </li>

    <li><strong>S159: Health-related quality of life of patients with chronic myeloid leukemia after discontinuation of tyrosine kinase inhibitors: Results from the EURO-SKI study</strong><br>
        F. Efficace, F.-X. Mahon, J. Richter, A. Piciocchi, M. Cipriani <em>et al.</em><br>
        <em>HemaSphere</em>, 7(S3), e0972454, 2023.
        <a href="https://doi.org/10.1097/01.HS9.0000967548.09724.54" target="_blank">DOI</a>
    </li>

    <li><strong>P523: The comparison of VFLAI, FLAI and 3+7 regimens by multilevel propensity score weighting highlights the benefit of the addition of venetoclax in no low-risk AML treated in GIMEMA trials and real world</strong><br>
        A. Piciocchi, G. Marconi, M. Cipriani <em>et al.</em><br>
        <em>HemaSphere</em>, 7(S3), e0034216, 2023.
        <a href="https://doi.org/10.1097/01.HS9.0000969000.00342.16" target="_blank">DOI</a>
    </li>

    <li><strong>P495: Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience</strong><br>
        A. Piciocchi, M. Cipriani, M. Messina, G. Marconi <em>et al.</em><br>
        <em>HemaSphere</em>, 7(S3), e4536536, 2023.
        <a href="https://doi.org/10.1097/01.HS9.0000968888.45365.36" target="_blank">DOI</a>
    </li>

    <li><strong>Addition of venetoclax to FLAI induction chemotherapy (VFLAI) improves survival in patients with intermediate and high-risk AML vs FLAI and 3+7: A GIMEMA Italian cooperative analysis</strong><br>
        G. Martinelli, M. Cipriani, G. Marconi, F. Guolo, P. Minetto, F. Paoloni, F. Cotugno <em>et al.</em><br>
        <em>Journal of Clinical Oncology</em>, 41(16 suppl), 2023.
        <a href="https://doi.org/10.1200/JCO.2023.41.16_suppl.7013" target="_blank">DOI</a>
    </li>

    <li><strong>Pseudo-observations in survival analysis</strong><br>
        M. Cipriani, A. Piciocchi, V. Arena, M. Alfò<br>
        Book of short papers SIS 2023 - Statistical Learning, Sustainability and Impact Evaluation, 2023. ISBN: 9788891935618
    </li>

    <li><strong>The Addition of Venetoclax to Induction Chemotherapy in No Low-Risk AML Patients: A Propensity Score-Matched Analysis of the Gimema AML1718 and AML1310 Trials</strong><br>
        A. Piciocchi, M. Messina, M. Cipriani, F. Paoloni <em>et al.</em><br>
        <em>Blood</em>, 140 (Suppl.1), 137–138, 2022.
        <a href="https://doi.org/10.1182/blood-2022-158890" target="_blank">DOI</a>
    </li>

    <li><strong>Health-Related Quality of Life and Financial Burden of Ethiopian Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors</strong><br>
        F. Tadesse, A. Gebremedhin, A. Abubeker, A. Piciocchi, M. Cipriani <em>et al.</em><br>
        <em>Blood</em>, 140 (Suppl.1), 5264–5265, 2022.
        <a href="https://doi.org/10.1182/blood-2022-163049" target="_blank">DOI</a>
    </li>


      </ul>
    </section>

  </div> <!-- end left column -->

  <!-- ===== COLONNA DESTRA ===== -->
  <div class="pub-column right">

    <!-- ===== PREPRINTS ===== -->
    <section>
      <h2>Preprints and under review</h2>
      <ul class="pub-list">

        <li><strong>Dynamic Prediction in Mixture Cure Models: A Model-Based Landmarking Approach</strong><br>
            M. Cipriani, M. Alfò, M. Signorelli<br>
            <em>arXiv</em>, 2025.
            <a href="https://doi.org/10.48550/arXiv.2509.18875" target="_blank">arXiv</a>
        </li>

        <li><strong>A multiple imputation approach to distinguish curative from life‑prolonging effects in the presence of missing covariates</strong><br>
            M. Cipriani, M. Fiocco, M. Alfò, M. Quelhas, E. Musta<br>
            <em>arXiv</em>, 2024.
            <a href="https://doi.org/10.48550/arXiv.2408.16485" target="_blank">arXiv</a>
        </li>

      </ul>
    </section>

  </div> <!-- end right column -->

</div> <!-- end pub-container -->

</body>
</html>
